What makes MDLinx Internal Medicine different from all the other primary care literature reviews? Our team of medical editors read over 2,000 medical journals every day so you can stay current in less than 5 minutes! They sort, rank and summarize every article that will impact your daily practice. They even mark which articles are available in free full text, which are clinical or evidence-based, and which have MDLinx Exclusive Author Commentary from the people who actually performed the research.
Also on this page you’ll see bonus content from our physician editor, D. Scott Cunningham, MD, PhD, in the form of his top highlights you can’t miss, along with clinical pearls from The Smartest Internist, a quiz competition from the editors of MDLinx Internal Medicine in collaboration with the Cleveland Clinic Center for Continuing Education.
Your Unread Messages in Internal Medicine
See All >> Messages include industry-sponsored communications and special communications from MDLinx
D Scott Cunningham MD, PhD
Site Editor, MDLinx
Outcome in MI patients with hyponatremia
Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage
Smartest Doc Challenge
MDLinx
Clinical Pearls for Hospitalists
MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools
MDLinx Top Read
MDLinx
Running from that pile of unread journals?
1 Prognostic Value of Bronchiectasis in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease American Journal of Respiratory and Critical Care Medicine, May 1, 2013 Clinical Article
2 COPD patient satisfaction with ipratropium bromide/albuterol delivered via Respimat: a randomized, controlled study Full Text International Journal of COPD, May 1, 2013 Clinical Article
3 Chronic treatment with indacaterol and airway response to salbutamol in stable COPD Respiratory Medicine, May 1, 2013 Clinical Article
4 High-Dose N-Acetylcysteine in the Prevention of COPD Exacerbations: Rationale and Design of the PANTHEON Study COPD: Journal of Chronic Obstructive Pulmonary Disease, May 1, 2013 Clinical Article
5 Safety and efficacy of the once-daily anticholinergic BEA2180 compared with tiotropium in patients with COPD Respiratory Medicine, May 1, 2013 Clinical Article
6 Electrocardiographic Characteristics of Patients with Chronic Obstructive Pulmonary Disease COPD: Journal of Chronic Obstructive Pulmonary Disease, May 1, 2013 Clinical Article
7 Nonlinear Exercise Training in Advanced COPD is Superior to Traditional Exercise Training: a Randomized Trial American Journal of Respiratory and Critical Care Medicine, May 1, 2013 Clinical Article
8 Efficacy and safety of the oral p38 inhibitor PH-797804 in chronic obstructive pulmonary disease: a randomised clinical trial Thorax, May 1, 2013 Clinical Article
9 Effect of fluticasone/salmeterol combination on dyspnea and respiratory mechanics in mild-to-moderate COPD Respiratory Medicine, April 2, 2013 Clinical Article
10 Use of tiotropium Respimat(R) SMI vs. tiotropium Handihaler(R) and mortality in patients with COPD European Respiratory Journal , April 2, 2013 Clinical Article
11 Peptic ulceration, Helicobacter Pylori seropositivity and Chronic Obstructive Pulmonary Disease Respirology, April 2, 2013 Review Article
12 Combination of budesonide/formoterol more effective than fluticasone/salmeterol in preventing exacerbations in chronic obstructive pulmonary disease. The PATHOS study Journal of Internal Medicine, April 2, 2013 Evidence Based Medicine Clinical Article
13 Three-year follow-up of Interleukin 6 and C-reactive protein in chronic obstructive pulmonary disease Full Text Respiratory Research, April 2, 2013 Clinical Article
14 Exploring the impact of screening with low-dose CT on lung cancer mortality in mild to moderate COPD patients: A pilot study Respiratory Medicine, April 2, 2013 Clinical Article
15 Measurement validity of an electronic inspiratory loading device during a loaded breathing task in patients with COPD Respiratory Medicine, April 2, 2013 Clinical Article
16 Simple functional performance tests and mortality in COPD European Respiratory Journal , April 2, 2013 Clinical Article
17 Supplemental vitamin D and physical performance in COPD: a pilot randomized trial Full Text International Journal of COPD, March 4, 2013 Clinical Article
18 Prevalence and characteristics of three clinical phenotypes of chronic obstructive pulmonary disease (COPD) Respiratory Medicine, March 4, 2013 Clinical Article
19 Sildenafil to improve respiratory rehabilitation outcomes in COPD: a controlled trial European Respiratory Journal , March 4, 2013 Clinical Article
Among 130 patients requiring mechanical ventilation, 107 were vitamin D-deficient (< 20 ng/ml). Of the patients who did not survive, the length of survival was shorter in the vitamin D-deficient patients (15.3 vs. 24.2 days, respectively).
Read the article summaryResearchers at Tel-Aviv University have conducted a study to determine the value of coronary artery calcium (CAC) measurements in cardiovascular risk stratification in patients with T2DM and HTN. The study involved 423 patients enrolled in the International Nifedipine Study: Intervention as Goal for Hypertension Therapy. The patients had baseline CT scans for CAC measurement at baseline and were shown to be free of disease. Follow-up CT scans were performed at 3 and 15 years. Cardiovascular events (CVEs) occurred in 41 of 423 patients at 3 years and 111 of 268 patients at 15 years of follow-up. CVEs occurred in 15% and 52% (CAC+) and 7% and 32% (CAC-) of patients with T2DM at 3 and 15 years of follow-up, respectively. Compared to patients without T2DM and no CAC, the HRs for a CVE were 6.6 and 3.9 in T2DM patients with and without CAC, respectively.
Read the article summaryResearchers at Erasmus University Medical Center in Rotterdam have evaluated 12 measures (N-terminal fragment of prohormone B-type natriuretic peptide levels, von Willebrand factor antigen levels, fibrinogen levels, chronic kidney disease, leukocyte count, C-reactive protein levels, homocysteine levels, uric acid levels, coronary artery calcium [CAC] scores, carotid intima–media thickness, peripheral arterial disease, and pulse wave velocity), in addition to Framingham risk scores for predicting coronary heart disease. Only the CAC was shown to add significantly to the Framingham risk score in predicting coronary heart disease.
Read the article summaryIndexed Journals in Internal Medicine: New England Journal of Medicine, The Lancet, Archives of Internal Medicine more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close